(Q24657539)

English

Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides (English)

0 references

1 reference

Emmet B Keeffe

1

0 references

Jean-François Rossignol

series ordinal

2

0 references

language of work or name

English

0 references

publication date

21 April 2009

0 references

published in

World Journal of Gastroenterology

0 references

volume

15

0 references

issue

15

0 references

page(s)

1805-8

0 references

cites work

Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

7 April 2017

Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

7 April 2017

Nitazoxanide: a review of its use in the treatment of gastrointestinal infections

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

7 April 2017

Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

28 September 2017

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

28 September 2017

Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

28 November 2018

Identifiers

DOI

10.3748/WJG.15.1805

0 references

Fatcat ID

release_cv44hxjur5drhdklzxuhfja3xy

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/cv44hxjur5drhdklzxuhfja3xy

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

2670405

0 references

PubMed publication ID

19370775

0 references

(Q24657539)

Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)